These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8621954)
1. Luminometry: a novel bioluminescent immunoassay enhances the quantitation of mucosal and systemic antibody responses. Jackson RJ; Fujihashi K; Kiyono H; McGhee JR J Immunol Methods; 1996 Apr; 190(2):189-97. PubMed ID: 8621954 [TBL] [Abstract][Full Text] [Related]
2. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. Elson CO; Ealding W J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359 [TBL] [Abstract][Full Text] [Related]
3. Mucosal immunity: regulation by helper T cells and a novel method for detection. Jackson RJ; Marinaro M; VanCott JL; Yamamoto M; Okahashi N; Fujihashi K; Kiyono H; Chatfield SN; McGhee JR J Biotechnol; 1996 Jan; 44(1-3):209-16. PubMed ID: 8717406 [TBL] [Abstract][Full Text] [Related]
4. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis. Blanchard TG; Lycke N; Czinn SJ; Nedrud JG Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182 [TBL] [Abstract][Full Text] [Related]
5. Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage. Externest D; Meckelein B; Schmidt MA; Frey A Infect Immun; 2000 Jul; 68(7):3830-9. PubMed ID: 10858191 [TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant. Siadat-Pajouh M; Cai L Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595 [TBL] [Abstract][Full Text] [Related]
7. Oral immunization with a free peptide from cholera toxin: local protection and IgA production. Pedoussaut S; Delmas A; Milhaud G; Rivaille P; Gruaz-Guyon A Mol Immunol; 1989 Feb; 26(2):115-9. PubMed ID: 2918857 [TBL] [Abstract][Full Text] [Related]
8. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant. Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383 [TBL] [Abstract][Full Text] [Related]
9. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289 [TBL] [Abstract][Full Text] [Related]
10. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. Elson CO; Ealding W J Immunol; 1984 Dec; 133(6):2892-7. PubMed ID: 6491278 [TBL] [Abstract][Full Text] [Related]
11. Application of a liposomal bioluminescent label in the development of a flow injection immunoanalytical system. Ho JA; Huang MR Anal Chem; 2005 Jun; 77(11):3431-6. PubMed ID: 15924372 [TBL] [Abstract][Full Text] [Related]
12. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice. Strindelius L; Filler M; Sjöholm I Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861 [TBL] [Abstract][Full Text] [Related]
13. Streptavidin-aequorin fusion protein for bioluminescent immunoassay. Inouye S; Sato J; Sasaki S; Sahara Y Biosci Biotechnol Biochem; 2011; 75(3):568-71. PubMed ID: 21389603 [TBL] [Abstract][Full Text] [Related]
14. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. Liang XP; Lamm ME; Nedrud JG J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395 [TBL] [Abstract][Full Text] [Related]
15. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice. Price GA; Russell MW; Cornelissen CN Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481 [TBL] [Abstract][Full Text] [Related]
16. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936 [TBL] [Abstract][Full Text] [Related]
17. Induction of an enteric Ig-response against ovalbumin and stimulation of the response by cholera toxin and its B-subunit in mice. Bianchi AT; Zwart RJ; Van der Heijden PJ Reg Immunol; 1990-1991; 3(3):131-8. PubMed ID: 2098068 [TBL] [Abstract][Full Text] [Related]
18. Purification of histidine-tagged aequorin with a reactive cysteine residue for chemical conjugations and its application for bioluminescent sandwich immunoassays. Inouye S; Sato J Protein Expr Purif; 2012 Jun; 83(2):205-10. PubMed ID: 22538315 [TBL] [Abstract][Full Text] [Related]
19. Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans. Wassen L; Jertborn M Clin Vaccine Immunol; 2006 Feb; 13(2):202-7. PubMed ID: 16467326 [TBL] [Abstract][Full Text] [Related]